Towards environmental dynamism
Market volatility and innovation capacity of pharmaceutical industry
DOI:
https://doi.org/10.12712/rpca.v.193.68669Resumo
The objective of this study is to examine the move towards environmental dynamism by investigating how market volatility, in the form of price fluctuation, demand uncertainty, and compliance intensity, influences the innovation capacity of the pharmaceutical industry in Nigeria. Up to 207 middle and top-level staff in Tuyil pharmaceutical industry were surveyed using structure questionnaire. Data obtained was analysed using PLS-SEM. Findings revealed that compliance intensity, price fluctuation, and demand uncertainty which are variables of market volatility all significantly affects innovation capacity with all p-values less than 0.05 and the T statistics greater than 1.96. In conclusion, market volatility aspect of environmental dynamism strongly affects the innovation capacity of pharmaceutical industry. It was recommended that pharmaceutical industries managers should focus on developing unique and appealing compliance intensity, price fluctuation, and demand uncertainty that can ensure a strong market volatility for their innovation capacity.
Downloads
Referências
Brown, A., & Chen, Y. (2023). Price volatility and innovation in the pharmaceutical sector. Health Economics Review, 33(2), 89-102.
Chan, K., Lee, J., & Woo, S. (2016). The impact of environmental dynamism on business strategies: An empirical analysis. Strategic Management Journal, 37(4), 725-737. https://doi.org/10.1002/smj.2359
Dao Le, T., Hsu, P.-H., & Chang, Y.-C. (2023). Enhancing competitive advantage through innovation capability: A case study of high-tech firms. Technovation, 129, 102610. https://doi.org/10.1016/j.technovation.2023.102610
Eun-Hwa, Choo, Absorptive, Organizational, & Innovation. (2025). . . . Between Environmental Dynamism, Absorptive Capacity, Organizational Ambidexterity, and Innovation Performance from the Dynamic Capabilities . . .. https://www.mdpi.com/2071-1050/17/2/449
Garcia, M., & Singh, R. (2022). Strategic innovation under pricing pressures in pharmaceuticals. Journal of Market Dynamics, 15(4), 201-214.
Johnson, L., & Patel, S. (2021). Demand uncertainty and innovation in dynamic markets. Strategic Management Journal, 42(4), 301-315.
Lee, H., & Kim, T. (2024). Adaptive innovation strategies in pharmaceuticals under market uncertainty. Journal of Pharmaceutical Economics, 29(1), 45-60.
Marco, & Giacomo. (2023). Learn to survive crises: The role of firm resilience, innovation capabilities and environmental dynamism. https://www.sciencedirect.com/science/article/pii/S0160791X23000908
Maria, George, & John. (2019). Big data analytics capabilities and innovation: the mediating role of dynamic capabilities and moderating effect of the environment. https://onlinelibrary.wiley.com/doi/abs/10.1111/1467-8551.12343
Mendez, J., & Alabi, O. (2023). Market volatility and operational efficiency in emerging markets. Journal of Business Research, 45(3), 112-125.
Nabila, Huma, Anam, Mahsa, Monica, green, & perceived. (2024). . . . social responsibility drive financial performance? Exploring the significance of green innovation, green dynamic capabilities, and perceived environmental volatility. https://onlinelibrary.wiley.com/doi/abs/10.1002/csr.2654
Odoom, I., & Mensah, M. (2019). The role of innovation capability in enhancing organizational performance: Evidence from Ghanaian firms. International Journal of Innovation Management, 23(1), 1950001. https://doi.org/10.1142/S1363919619500018
Sabeen, Aamir, Environmental, & Implication. (2025). Eco-Innovation, Environmental Performance, and Implication of Transient Competitive Advantage in Pharmaceutical Industry of Pakistan. https://journals.irapa.org/index.php/BMS/article/view/1085
Seo, H., Park, J., & Choi, Y. (2020). Environmental dynamism and organizational adaptability: The role of external factors in business performance. Journal of Business Research, 120, 456-467. https://doi.org/10.1016/j.jbusres.2020.07.041
Shen, Abdul, Tze, Badar, & Mohsin. (2022). Fostering green innovation adoption through green dynamic capability: The moderating role of environmental dynamism and big data analytic capability. https://www.mdpi.com/1660-4601/19/16/10336
Smith, R., & Kumar, P. (2022). Regulatory compliance as a driver of innovation in pharmaceuticals. Pharmaceutical Innovation Journal, 18(2), 78-89.
Sohaib. (2025). Innovation Dynamic Performance in the Pharmaceutical Industry: A Study on Establishing a Generic Strategic Planning. http://jbmr.com.pk/index.php/Journal/article/view/405
Sohrab, & Atieh. (2020). Business environment: Designing and explaining the new environmental dynamism model in pharmacies. https://www.academia.edu/download/65843147/a9f5984e-dd73-11ea-b952-5306e69525a5.pdf
Ugur, & Meltem. (2017). Knowledge process capabilities and innovation: testing the moderating effects of environmental dynamism and strategic flexibility. https://www.tandfonline.com/doi/abs/10.1057/s41275-017-0068-4
Downloads
Publicado
Edição
Seção
Licença
Os autores mantêm os direitos autorais e concedem à revista o direito de primeira publicação, com o trabalho simultaneamente licenciado sob a Creative Commons Attribution License, permitindo o compartilhamento do trabalho com reconhecimento da autoria e publicação inicial nesta revista.
A Revista usa o CC BY. Essa licença permite que outras pessoas distribuam, remixem, adaptem e desenvolvam seu trabalho, mesmo comercialmente, desde que sejam creditadas pela criação original. Essa é a licença mais flexível oferecida. Recomendado para máxima disseminação e uso de materiais licenciados.
Os autores têm autorização para assumir contratos adicionais separadamente, para distribuição não-exclusiva da versão do trabalho publicada nesta revista (ex.: publicar em repositório institucional ou como capítulo de livro), sempre com reconhecimento de autoria e publicação inicial nesta revista.
A Revista ulitiliza o DOI (Digital Object Identifier ) desde 2007 O DOI com a finalidade de autenticar cada artigo, portanto seu conteúdo digital.
